“Influence Of Eudragit RSPO And Polycaprolactone On The Release Rate And In Vitro Evaluation In The Formulation Of Sustained Release Orlistat Matrix Microparticles”. Journal of Pharmaceutical Negative Results (November 5, 2022): 1271–1284. Accessed June 30, 2026. https://pnrjournal.com/index.php/home/article/view/2951.